As of Sep 23
| +2.10 / +3.18%|
The 6 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 65.50, with a high estimate of 89.00 and a low estimate of 54.00. The median estimate represents a -3.79% decrease from the last price of 68.08.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.